Straumann Holding AG
SIX:STMN
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
105.9
150.95
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one STMN stock under the Base Case scenario is 130.32 CHF. Compared to the current market price of 111.5 CHF, Straumann Holding AG is Undervalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Straumann Holding AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for STMN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Straumann Holding AG, a leader in dental implant and restorative solutions, has carved out a significant niche in the global dental market. Founded in 1954 in Switzerland, the company has evolved from a small manufacturer into a powerhouse known for its emphasis on innovation and quality. With a portfolio that includes dental implants, prosthetics, digital dentistry, and orthodontic solutions, Straumann has positioned itself at the forefront of cutting-edge oral healthcare technologies. By leveraging advanced research and development, the company continually enhances its offerings, ensuring that dental professionals have access to the most effective tools for restoring patients' smiles and m...
Straumann Holding AG, a leader in dental implant and restorative solutions, has carved out a significant niche in the global dental market. Founded in 1954 in Switzerland, the company has evolved from a small manufacturer into a powerhouse known for its emphasis on innovation and quality. With a portfolio that includes dental implants, prosthetics, digital dentistry, and orthodontic solutions, Straumann has positioned itself at the forefront of cutting-edge oral healthcare technologies. By leveraging advanced research and development, the company continually enhances its offerings, ensuring that dental professionals have access to the most effective tools for restoring patients' smiles and maintaining oral health.
For investors, Straumann represents a robust opportunity in the steadily growing dental market, fueled by an increasing global focus on aesthetics and oral care. The company’s strategy of strategic acquisitions, expansion into emerging markets, and commitment to sustainability underlines its long-term growth potential. Furthermore, Straumann’s strong financial performance, characterized by consistent revenue growth and significant profit margins, highlights its operational efficiency and market leadership. As dental health becomes a priority for populations worldwide, Straumann Holding AG stands ready to capitalize on these trends, making it a compelling consideration for those looking to invest in a resilient and innovative industry.
Straumann Holding AG is a global leader in the dental implant and oral rehabilitation market. Its core business segments can be broadly categorized as follows:
-
Dental Implants: This is the flagship segment of Straumann, where the company offers a wide range of dental implant systems. These products are designed for various clinical applications, enabling dental professionals to restore patient smiles effectively.
-
Restorative Solutions: This segment includes products that support the restoration of dental implants, such as crowns, bridges, and other prosthetic devices. Straumann provides various materials, including ceramics and composite resins, which are essential for effective restoration procedures.
-
Digital Solutions: With the increasing integration of digital technologies in dentistry, Straumann has invested in digital solutions such as CAD/CAM (Computer-Aided Design and Manufacturing), 3D printing, and digital workflow tools. These technologies enhance the precision and efficiency of dental procedures.
-
Orthodontics: Straumann has expanded its product portfolio to include orthodontic solutions, primarily focused on clear aligners. This segment addresses the growing demand for aesthetic orthodontic treatments.
-
Tissue Regeneration: This segment focuses on products that promote the regeneration of dental tissues, including bone and soft tissue. Straumann offers a range of biomaterials that aid in successful implant procedures and overall oral health.
-
Software Solutions: Alongside hardware products, Straumann develops software platforms that assist dental professionals in treatment planning, patient management, and data analysis, streamlining various aspects of dental practices.
These segments collectively position Straumann as a comprehensive provider in the dental field, catering to the needs of both dental professionals and patients through innovative and high-quality solutions.
Straumann Holding AG, a leading player in the dental implant and oral tissue regeneration market, possesses several unique competitive advantages that distinguish it from its rivals:
-
Strong Brand Reputation: Straumann has built a strong global brand recognized for high-quality products and innovative solutions. Its reputation allows it to command premium pricing and maintain customer loyalty.
-
Focus on Innovation: The company invests significantly in research and development, leading to a robust pipeline of innovative products. This commitment to innovation enables Straumann to stay ahead of trends and offer advanced solutions that fulfill unmet needs in the dentistry field.
-
Comprehensive Product Portfolio: Straumann offers a wide range of products including dental implants, prosthetics, and regenerative solutions. This comprehensive portfolio allows it to serve various customer segments and encourages cross-selling opportunities.
-
Strong Distribution Network: The company possesses an extensive global distribution network, which facilitates efficient supply chain management and allows for quick delivery of products to customers around the world.
-
Strategic Acquisitions: Straumann has a history of strategic acquisitions that have bolstered its product offerings and market presence. Noteworthy acquisitions have added advanced technologies and complementary products to its portfolio.
-
High-Quality Manufacturing Standards: Straumann is known for its stringent manufacturing standards and quality control processes, which minimize defects and ensure product reliability.
-
Excellent Training and Support: The company provides comprehensive training programs and support for dental professionals, helping users effectively implement and utilize their products. This enhances customer satisfaction and loyalty.
-
Strong Financial Performance: Healthy financial metrics and a solid balance sheet enable Straumann to invest in growth initiatives while weathering market volatility better than many competitors.
-
Global Reach with Local Expertise: Although it operates globally, Straumann tailors its approach to local markets, understanding regional preferences, regulations, and competitive dynamics.
-
Commitment to Sustainability: As sustainability becomes increasingly important in business practices, Straumann's focus on environmentally friendly operations can provide a competitive edge, appealing to both consumers and investors who prioritize sustainability.
These advantages contribute to Straumann's leadership position in the dental market, allowing it to effectively compete against its rivals and sustain long-term growth.
As a professional business analyst, it’s important to consider various risk factors and challenges that a company like Straumann Holding AG, which specializes in dental implants and related products, might face in the near future. Here are some key risks and challenges:
-
Regulatory Changes: The dental and medical device industries are highly regulated. Changes in regulations regarding safety, efficacy, or market approval could impact product lines and development timelines.
-
Market Competition: The dental implant market is competitive, with several established players and new entrants. Increased competition can lead to price wars, reduced market share, and pressure on margins.
-
Economic Conditions: Global economic fluctuations can impact consumer spending in healthcare services. Economic downturns may result in reduced expenditures on elective procedures such as dental implants.
-
Technological Advancements: Rapid technological changes in dental procedures or materials could render existing products obsolete. Keeping pace with innovation is crucial for maintaining competitive advantage.
-
Supply Chain Disruptions: Global supply chain issues, exacerbated by geopolitical tensions, pandemics, or natural disasters, can disrupt production and distribution, affecting sales and profitability.
-
Reputation Risk: As a healthcare company, Straumann must maintain high standards of product safety and efficacy. Any negative publicity, whether from product recalls or adverse patient outcomes, could harm its reputation and customer trust.
-
Research and Development Costs: Investing in R&D is crucial for product innovation but comes with risks. Failed projects can lead to significant financial loss, and there’s always uncertainty around the successful development and commercialization of new products.
-
Intellectual Property Risks: Protecting intellectual property is vital in maintaining a competitive edge. Theft, patent infringement, or challenges from competitors can pose significant risks.
-
Global Market Risks: Operating in multiple international markets exposes Straumann to various risks, including currency fluctuations, political instability, and differing market dynamics and regulatory environments.
-
Shifts in Consumer Preferences: Changes in consumer preferences towards less invasive dental solutions, alternative therapies, or advancements in technology (like teledentistry) could impact demand for traditional dental implant products.
-
Talent Acquisition and Retention: As a technology-driven industry, attracting and retaining skilled professionals, especially in R&D and sales, is critical. A shortage of skilled labor can hinder growth and innovation.
By carefully analyzing these risks and actively developing strategies to mitigate them, Straumann can position itself to navigate the challenges ahead.
Revenue & Expenses Breakdown
Straumann Holding AG
Balance Sheet Decomposition
Straumann Holding AG
Current Assets | 1.5B |
Cash & Short-Term Investments | 343.9m |
Receivables | 601.7m |
Other Current Assets | 581m |
Non-Current Assets | 2B |
Long-Term Investments | 200.9m |
PP&E | 717.8m |
Intangibles | 894.9m |
Other Non-Current Assets | 138.3m |
Current Liabilities | 723m |
Accounts Payable | 473.5m |
Other Current Liabilities | 249.5m |
Non-Current Liabilities | 787.4m |
Long-Term Debt | 423m |
Other Non-Current Liabilities | 364.4m |
Earnings Waterfall
Straumann Holding AG
Revenue
|
2.5B
CHF
|
Cost of Revenue
|
-672.2m
CHF
|
Gross Profit
|
1.8B
CHF
|
Operating Expenses
|
-1.3B
CHF
|
Operating Income
|
481.3m
CHF
|
Other Expenses
|
-210.6m
CHF
|
Net Income
|
270.7m
CHF
|
Free Cash Flow Analysis
Straumann Holding AG
CHF | |
Free Cash Flow | CHF |
In Q3 2024, Straumann Group reported an impressive organic revenue growth of 11.2%, totaling CHF 586 million, and confirming a full-year growth outlook of low double digits. The EMEA region was a standout performer with an 11.4% increase, driven by new products like the SIRIOS intraoral scanner. However, North America faced challenges due to high interest rates impacting patient consultations. Despite these hurdles, the company anticipates continued market share gains and is optimistic for Q4 as new product launches like iEXCEL are expected to boost results. Profitability is projected to remain between 27% and 28% at constant currency rates.
What is Earnings Call?
STMN Profitability Score
Profitability Due Diligence
Straumann Holding AG's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Straumann Holding AG's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
STMN Solvency Score
Solvency Due Diligence
Straumann Holding AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Score
Straumann Holding AG's solvency score is 83/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STMN Price Targets Summary
Straumann Holding AG
According to Wall Street analysts, the average 1-year price target for STMN is 139.26 CHF with a low forecast of 101 CHF and a high forecast of 183.75 CHF.
Dividends
Current shareholder yield for STMN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
STMN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Straumann Holding AG is a CH-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Basel, Basel-Stadt and currently employs 9,054 full-time employees. Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Contact
IPO
Employees
Officers
The intrinsic value of one STMN stock under the Base Case scenario is 130.32 CHF.
Compared to the current market price of 111.5 CHF, Straumann Holding AG is Undervalued by 14%.